Journal of Advances in Molecular Biology
In Silico Comparison of Synthetic and Natural Molecules Bindings with Acetylcholinesterase Enzyme using Molecular Docking
Download PDF (1549.9 KB) PP. 17 - 26 Pub. Date: September 1, 2018
Author(s)
- Fouzia Mesli
Laboratory of Naturals Products and Bioactives- LASNABIO, University of Tlemcen. B. P. 119, 13000 Tlemcen. Algeria - Salim Bouchentouf*
Laboratory of Naturals Products and Bioactives- LASNABIO, University of Tlemcen. B. P. 119, 13000 Tlemcen. Algeria;Faculty of Technology, Doctor Tahar Moulay University of Saida, Algeria - Amina Ghomri
Laboratory of Naturals Products and Bioactives- LASNABIO, University of Tlemcen. B. P. 119, 13000 Tlemcen. Algeria;High school of Applied Sciences ESSA Tlemcen. B. P. 165, 13000 Tlemcen. Algeria - Noureddine Missoum
Laboratory of Naturals Products and Bioactives- LASNABIO, University of Tlemcen. B. P. 119, 13000 Tlemcen. Algeria;Faculty of Scineces, Hassiba Benbouali University of Chlef, Algeria - Said Ghalem
Laboratory of Naturals Products and Bioactives- LASNABIO, University of Tlemcen. B. P. 119, 13000 Tlemcen. Algeria
Abstract
Keywords
References
[1] Querfurth HW, LaFerla FM (2010) Alzheimer's disease. The New England Journal of Medicine 28 January 362 (4): 329–44.
[2] Todd S, Barr S, Roberts M, Passmore, AP (2013) Survival in dementia and predictors of mortality: a review. International Journal of Geriatric Psychiatry November 28 (11): 1109–24.
[3] Katergaris N, Dufficy L, Roach PD, Naumovski N (2015) Green tea catechins as neuroprotective agents: systematic review of the literature in animalpre-clinical trials. Adv Food Technol Nutr Sci Open J 1(2): 48-57.
[4] Lane, Roger M, Miia Kivipelto, and Nigel H (2004) Greig. Acetylcholinesterase and its inhibition in Alzheimer disease. Clinical neuropharmacology 27(3): 141-149.
[5] Khan MA, Hussain, A, Sundaram MK, et al. (2015) (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncol Rep 33(4): 1976-1984.
[6] Nabavi SM, Daglia M, Moghaddam AH, Nabavi SF, Curti V (2014) Tea consumption and risk of ischemic stroke: a brief review of the literature. Curr Pharm Biotechnol 15(4): 298-303.
[7] Matsushita K (2014) Epigallocatechin gallate suppresses LPS endocytosis and nitric oxide production by reducing Rab5-caveolin-1 interaction.Biomed Res. 35(2): 145-151.
[8] Cai J, Jing D, Shi M, et al. (2014) Epigallocatechin gallate (EGCG) attenuates infrasound-induced neuronal impairment by inhibiting microglia-mediated inflammation J Nutr Biochem 25(7): 716-725.
[9] Vuong QV, Golding JB, Nguyen M, Roach PD (2010) Extraction and isolation of catechins from tea. J Sep Sci 33(21): 3415-3428.
[10] Lee HS, Jun JH, Jung EH, Koo BA, Kim YS (2014)Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Molecules 19(8):12150-12172.
[11] Betts JW, Wareham DW (2014) In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol 14, 172
[12] Reygaert WC (2014) The antimicrobial possibilities of green tea. Front Microbiol 5, 434.
[13] Saiko P, Steinmann MT, Schuster H, et al. (2015) Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine. Phytomedicine 22 (1): 213-222.
[14] Sussman JL, Harel M, Silman I. (1993) Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs. Chem. Biol. Interact. June 87 (1–3): 187–97.
[15] Colovic MB, Krstic, Danijela Z, Lazarevic-Pasti, Tamara D, Bondzic, Aleksandra M, Vasic, Vesna M (2013) Acetylcholinesterase Inhibitors: Pharmacology and Toxicology. Current Neuropharmacology 11 (3): 315–335.
[16] Bezerra da Silva, Cristiane, et al. (2016) Effect of donepezil, tacrine, galantamine and rivastigmine on acetylcholinesterase inhibition in Dugesia tigrina. Molecules 21.1: 53.
[17] Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K (1992) Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[5, 6-dimethoxy-1-indanon-2-yl] methylpiperidine hydrochloride (E2020) and related compounds. Bioorg Med Chem Lett 2: 871–876
[18] Anand R, Gharabawi G, Enz A (1996) Efficacy and safety results of the early phase studies with Exelon (ENA 713) in Alzheimer's disease: an overview. J Drug Dev Clin Pract 8: 109–116.
[19] Heinrich M, Teoh HL (1992) Galanthamine from snowdrop – the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. Journal of Ethnopharmacology (2–3): 147–162.
[20] Selen A, Balogh L, Siedlik P (1988) Pharmacokinetics of tacrine in healthy subjects. Pharm Res. 5: 218.
[21] Raja S (2017) INVESTIGATION OF HEPATOPROTECTIVE AND ANTIOXIDANT ACTIVITIES OF INDIAN MEDICINAL PLANTS.
[22] Molecular Operating Environment (MOE), Chemical Computing Group, Montreal, Quebec, Canada10, 2013.
[23] Powers JP, Piper DE, Li Y, Mayorga V, Anzola J, Chen JM, et al. (2006) SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. J Med Chem 49(3).
[24] Goto J, Kataoka R, Muta H, and al. (2008) ASEDock-docking based on alpha spheres and excluded volumes J Chem Inf Model 48, 583-590.
[25] Manikrao AM, Mahajan1 NS, Jawarkar RD, Mahajan DT, Masand2 VH, TBen Hadda (2011) Docking Studies of few C-3 Substituted Azapteridines as Hepatitis C Virus RNA-Dependent RNA Polymerase inhibitors Scholars Research Library. J. Comput. Method. Mol. Design 35-45.
[26] Labute P, Williams C, Feher M, Sourial E, Schmidt JM. (2001) Flexible alignment of small molecules J. Med. Chem. 44:1483-1490.
[27] (a) Clark AM, Labute P, Santavy M (2006) Journal of chemical information and modeling . J. Chem.46, Inf. Model. 1107-1123.
[28] Clark AM, Labute P (2008) Clark, A. M., & Labute, P. (2008). Detection and assignment of common scaffolds in project databases of lead molecules J. Med. Chem. 52: 469-483
[29] Ritchie D, Macromolecular Docking Using Spherical Polar Fourier Correlations, Department of Computing Science, University of Aberdeen, copyright ? 1996-2005
[30] Yamaguchi H, Kamiie K, Kidachi Y, Noshita T, Umetsu H, Fuke, Y, Ryoyama K (2014). Intracellular accumulation of structurally varied isothiocyanates correlates with inhibition of nitric oxide production in proinflammatory stimuli-activated tumorigenic macrophage-like cells. Bioorganic & medicinal chemistry 22(1): 440-446.
[31] Lipinski CA. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies.1 (4):337-342.
[32] Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev.23:3–25.